Paris Claudia, Zepeda Ana, Muñoz Mónica, Camus Adela, Catalán Paula, Sotomayor Cristián, Luengo Rosario, Schulin-Zeuthem Carolina, Brieba Mariela, Romero Patricia
Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
Escuela de Tecnología Médica, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile.
Andes Pediatr. 2022 Feb;93(1):19-26. doi: 10.32641/andespediatr.v93i1.3693. Epub 2021 Sep 8.
The increased survival of children and adolescents after Stem Cell Transplantation (SCT) has allowed us to gain a better understanding of the late effects that this procedure might have.
to measure ovarian function and reserve after SCT.
A descriptive, observatio nal, and cross-sectional study of girls and adolescents with SCT between 1999 and 2011. External gynecologic examination, hormone tests, and abdominal gynecologic ultrasound were performed, observing pubertal development pre-SCT. The following data from the clinical record were recorded: baseline pathology, type of conditioning, use of radiotherapy in conditioning, age at the time of SCT, and history of acute or chronic graft-versus-host disease (GVHD). Hormonal tests included follicle- stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin (PRL), thyroid-stimula ting hormone (TSH), free thyroxine, total testosterone, sex hormone-binding globulin (SHBG), and anti-Müllerian hormone (AMH). Statistical analysis included the chi-square or Fisher's Exact test with a p-value < 0.05.
41 patients were evaluated. The median age at the time of SCT was 6.8 years (1.5-14.1) and the median age at evaluation was 14.8 years (range: 4-25.4 years). 93% of the transplants were in patients with oncological disease and with myeloablative conditioning regimens. All patients presented decreased ovarian reserve, and 72% showed Premature Ovarian Failure (POF).
All patients had decreased ovarian reserve and most of them had a high prevalence of POF. Before SCT, a gynecological evaluation and subsequent follow-up for hormone monitoring and initiation of hormone replacement are essential.
儿童和青少年干细胞移植(SCT)后生存率的提高使我们能够更好地了解该手术可能产生的晚期影响。
测量干细胞移植后的卵巢功能和储备。
对1999年至2011年间接受干细胞移植的女孩和青少年进行描述性、观察性横断面研究。进行了外部妇科检查、激素检测和腹部妇科超声检查,观察干细胞移植前的青春期发育情况。记录临床记录中的以下数据:基线病理、预处理类型、预处理中放疗的使用、干细胞移植时的年龄以及急性或慢性移植物抗宿主病(GVHD)病史。激素检测包括促卵泡激素(FSH)、促黄体生成素(LH)、雌二醇、催乳素(PRL)、促甲状腺激素(TSH)、游离甲状腺素、总睾酮、性激素结合球蛋白(SHBG)和抗苗勒管激素(AMH)。统计分析采用卡方检验或Fisher精确检验,p值<0.05。
评估了41例患者。干细胞移植时的中位年龄为6.8岁(1.5 - 14.1岁),评估时的中位年龄为14.8岁(范围:4 - 25.4岁)。93%的移植患者患有肿瘤疾病并采用了清髓性预处理方案。所有患者的卵巢储备均下降,72%表现为卵巢早衰(POF)。
所有患者的卵巢储备均下降,且大多数患者卵巢早衰的患病率较高。在干细胞移植前,进行妇科评估以及随后的激素监测随访和激素替代治疗启动至关重要。